ARCHIVES

First Compound From New In Vitro Screening to Enter Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Sharfstein To Leave FDA

January 7, 2011

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984